{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:20:50Z","timestamp":1790882450189,"version":"4.1.0"},"reference-count":55,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:00:00Z","timestamp":1769817600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS124081 to J.S.Y. and J.Z., R01NS145466 to J.S.Y. and L.X., R01NS130798 to J.S.Y., U54 CA274513 to J.S.Y., S10 OD030398 to B.B.W."],"award-info":[{"award-number":["R01NS124081 to J.S.Y. and J.Z., R01NS145466 to J.S.Y. and L.X., R01NS130798 to J.S.Y., U54 CA274513 to J.S.Y., S10 OD030398 to B.B.W."]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"VeloSano to J.S.Y., Cleveland Clinic to J.S.Y., Case Comprehensive Cancer Center to J.S.Y., Amy Post Fund to J.S.Y., and Falk Foundation Medical Research Trust to J.S.Y."}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Genomic stability is essential for cell survival, particularly under stress conditions like hypoxia, which disrupt DNA repair. Glioblastoma (GBM) is markedly resistant to DNA-damaging therapies, primarily due to glioma stem cells (GSCs) and the hypoxic tumor microenvironment. Long non-coding RNAs (lncRNAs) play a significant role in maintaining genome integrity, but their involvement in the DNA damage response (DDR) under hypoxic conditions in GSCs remains unclear. We previously identified LUCAT1 as the most highly induced lncRNA in GSCs under hypoxia and a key regulator HIF1\u03b1 activity. We now investigate its role in DDR regulation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>LUCAT1-interacting proteins in GSCs under hypoxia were identified using identification of direct RNA interacting proteins (iDRIP) and mass spectrometry. Interactions were confirmed by RNA pulldown and RNA \u00adimmunoprecipitation. Mechanistic studies involved immunoprecipitation, proximity ligation assays, comet assays, immunostaining, and LUCAT1 knockdown using shRNA. Gene expression changes were evaluated via RNAseq in GSCs and TCGA datasets. Functional assays were conducted in GSCs and orthotopic xenografts with LUCAT1 depletion alone or in combination with PARP or DNA-PK inhibition or radiation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>LUCAT1 directly interacts with the DNA-PK holoenzyme, modulating its assembly and function in the non-homologous end joining (NHEJ) pathway. It also regulates BRCA1 and RAD51, key proteins in homologous recombination (HR). Depletion of LUCAT1 increased DNA damage, sensitized GSCs to DDR inhibitors, and improved survival in mice treated with radiotherapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>LUCAT1 is a critical DDR regulator in GSCs under hypoxia and a promising target to enhance the \u00adefficacy of DDR inhibitors and radiotherapy in GBM.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/neuonc\/noag017","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T12:14:17Z","timestamp":1769516057000},"page":"1179-1192","source":"Crossref","is-referenced-by-count":2,"title":["lncRNA LUCAT1 regulates DNA damage response in glioma stem cells under hypoxia"],"prefix":"10.1093","volume":"28","author":[{"given":"Haidong","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Cancer Sciences, Cleveland Clinic , Cleveland, OH,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hariti","family":"Shah","sequence":"additional","affiliation":[{"name":"Department of Cancer Sciences, Cleveland Clinic , Cleveland, OH,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Himanshu","family":"Dashora","sequence":"additional","affiliation":[{"name":"Department of Cancer Sciences, Cleveland Clinic , Cleveland, OH,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly","family":"Guthrie","sequence":"additional","affiliation":[{"name":"Department of Cancer Sciences, Cleveland Clinic , Cleveland, OH,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilah","family":"MacLowry","sequence":"additional","affiliation":[{"name":"Department of Cancer Sciences, Cleveland Clinic , Cleveland, OH,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Cancer Sciences, Cleveland Clinic , Cleveland, OH,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalya","family":"Khalife","sequence":"additional","affiliation":[{"name":"Department of Cancer Sciences, Cleveland Clinic , Cleveland, OH,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhong","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Cancer Sciences, Cleveland Clinic , Cleveland, OH,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shideng","family":"Bao","sequence":"additional","affiliation":[{"name":"Department of Cancer Sciences, Cleveland Clinic , Cleveland, OH,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Prayson","sequence":"additional","affiliation":[{"name":"Department of Pathology, Cleveland Clinic , Cleveland, OH,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangqi","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Cancer Sciences, Cleveland Clinic , Cleveland, OH,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Cancer Sciences, Cleveland Clinic , Cleveland, OH,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0244-4014","authenticated-orcid":false,"given":"Jennifer S","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Cleveland Clinic , Cleveland, OH,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,1,31]]},"reference":[{"key":"2026051916122336500_noag017-B1","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41392-023-01332-8","article-title":"Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"2026051916122336500_noag017-B2","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/nrc2344","article-title":"Hypoxia, DNA repair and genetic instability","volume":"8","author":"Bristow","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"2026051916122336500_noag017-B3","article-title":"Chen Z, Han F, Du Y. et al. Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions","journal-title":"Sig Transduct Targeted Ther"},{"key":"2026051916122336500_noag017-B4","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/s41588-018-0318-2","article-title":"Molecular landmarks of tumor hypoxia across cancer types","volume":"51","author":"Bhandari","year":"2019","journal-title":"Nat Genet"},{"key":"2026051916122336500_noag017-B5","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1158\/1078-0432.CCR-20-3580","article-title":"Tissue hypoxia and alterations in microvascular architecture predict glioblastoma recurrence in humans","volume":"27","author":"Stadlbauer","year":"2021","journal-title":"Clin Cancer Res"},{"key":"2026051916122336500_noag017-B6","doi-asserted-by":"publisher","first-page":"e11275","DOI":"10.7717\/peerj.11275","article-title":"Downregulation of both mismatch repair and non-homologous end-joining pathways in hypoxic brain tumour cell lines","volume":"9","author":"Cowman","year":"2021","journal-title":"PeerJ"},{"key":"2026051916122336500_noag017-B7","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1101\/gad.261982.115","article-title":"Cancer stem cells in glioblastoma","volume":"29","author":"Lathia","year":"2015","journal-title":"Genes Dev"},{"key":"2026051916122336500_noag017-B8","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1101\/gad.324301.119","article-title":"Glioblastoma stem cells: lessons from the tumor hierarchy in a lethal cancer","volume":"33","author":"Gimple","year":"2019","journal-title":"Genes Dev"},{"key":"2026051916122336500_noag017-B9","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/nature05236","article-title":"Glioma stem cells promote radioresistance by preferential activation of the DNA damage response","volume":"444","author":"Bao","year":"2006","journal-title":"Nature"},{"key":"2026051916122336500_noag017-B10","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/1471-2407-14-151","article-title":"Pharmacological inhibition of poly(ADP-ribose) polymerase-1 modulates resistance of human glioblastoma stem cells to temozolomide","volume":"14","author":"Tentori","year":"2014","journal-title":"BMC Cancer"},{"key":"2026051916122336500_noag017-B11","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1158\/0008-5472.CAN-15-1884","article-title":"The error-prone DNA polymerase \u03ba \u00adpromotes temozolomide resistance in glioblastoma through Rad17-dependent activation of ATR-Chk1 signaling","volume":"76","author":"Peng","year":"2016","journal-title":"Cancer Res"},{"key":"2026051916122336500_noag017-B12","doi-asserted-by":"publisher","first-page":"550","DOI":"10.15252\/emmm.201505890","article-title":"MET inhibition overcomes radiation resistance of glioblastoma stem-like cells","volume":"8","author":"De Bacco","year":"2016","journal-title":"EMBO Mol Med"},{"key":"2026051916122336500_noag017-B13","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1158\/0008-5472.CAN-14-3621","article-title":"Hyperthermia sensitizes glioma stem-like cells to radiation by inhibiting AKT signaling","volume":"75","author":"Man","year":"2015","journal-title":"Cancer Res"},{"key":"2026051916122336500_noag017-B14","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s43018-022-00510-x","article-title":"Integrative multi-omics networks identify PKC\u03b4 and DNA-PK as master kinases of glioblastoma subtypes and guide targeted cancer therapy","volume":"4","author":"Migliozzi","year":"2023","journal-title":"Nat Cancer"},{"key":"2026051916122336500_noag017-B15","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1093\/neuonc\/noae036","article-title":"Long non-coding RNA lung cancer-associated transcript-1 promotes glioblastoma progression by enhancing hypoxia-inducible factor 1 alpha activity","volume":"26","author":"Huang","year":"2024","journal-title":"Neuro Oncol"},{"key":"2026051916122336500_noag017-B16","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.ccell.2017.02.009","article-title":"The microenvironmental landscape of brain tumors","volume":"31","author":"Quail","year":"2017","journal-title":"Cancer Cell"},{"key":"2026051916122336500_noag017-B17","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.stem.2017.10.005","article-title":"Hypoxic induction of vasorin regulates Notch1 turnover to maintain glioma stem-like cells","volume":"22","author":"Man","year":"2018","journal-title":"Cell Stem Cell"},{"key":"2026051916122336500_noag017-B18","doi-asserted-by":"publisher","first-page":"108522","DOI":"10.1016\/j.celrep.2020.108522","article-title":"Piwil1 regulates glioma stem cell maintenance and glioblastoma progression","volume":"34","author":"Huang","year":"2021","journal-title":"Cell Rep"},{"key":"2026051916122336500_noag017-B19","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/nrc2397","article-title":"Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response","volume":"8","author":"Dewhirst","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"2026051916122336500_noag017-B20","doi-asserted-by":"publisher","first-page":"442","DOI":"10.2174\/156652409788167087","article-title":"Hypoxia and radiation therapy: past history, ongoing research, and future promise","volume":"9","author":"Rockwell","year":"2009","journal-title":"Curr Mol Med"},{"key":"2026051916122336500_noag017-B21","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1093\/NEUONC\/NOW258","article-title":"Hypoxia in the glioblastoma microenvironment: shaping the phenotype of cancer stem-like cells","volume":"19","author":"Colwell","year":"2017","journal-title":"Neuro Oncol"},{"key":"2026051916122336500_noag017-B22","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/mutage\/gez019","article-title":"Impact of hypoxia on DNA repair and genome integrity","volume":"35","author":"Kaplan","year":"2020","journal-title":"Mutagenesis"},{"key":"2026051916122336500_noag017-B23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.semcancer.2023.11.006","article-title":"Tumor hypoxia and radiotherapy: a major driver of resistance even for novel radiotherapy modalities","volume":"98","author":"Beckers","year":"2024","journal-title":"Semin Cancer Biol"},{"key":"2026051916122336500_noag017-B24","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1038\/cdd.2008.47","article-title":"Death through a tragedy: mitotic catastrophe","volume":"15","author":"Vakifahmetoglu","year":"2008","journal-title":"Cell Death Differ"},{"key":"2026051916122336500_noag017-B25","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.clon.2019.06.008","article-title":"Tumour hypoxia","volume":"31","author":"West","year":"2019","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"2026051916122336500_noag017-B26","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.molcel.2017.05.015","article-title":"ATM, ATR, and DNA-PK: the Trinity at the heart of the DNA damage response","volume":"66","author":"Blackford","year":"2017","journal-title":"Mol Cell"},{"key":"2026051916122336500_noag017-B27","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/s41392-021-00648-7","article-title":"DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy","volume":"6","author":"Huang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"2026051916122336500_noag017-B28","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/emboj.2008.15","article-title":"DNA-damage repair; the good, the bad, and the ugly","volume":"27","author":"Hakem","year":"2008","journal-title":"Embo J"},{"key":"2026051916122336500_noag017-B29","doi-asserted-by":"publisher","first-page":"10524","DOI":"10.1074\/jbc.TM118.000372","article-title":"Homologous recombination and the repair of DNA double-strand breaks","volume":"293","author":"Wright","year":"2018","journal-title":"J Biol Chem"},{"key":"2026051916122336500_noag017-B30","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/s41580-020-00297-8","article-title":"The molecular basis and disease relevance of non-homologous DNA end joining","volume":"21","author":"Zhao","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2026051916122336500_noag017-B31","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41556-018-0066-7","article-title":"GUARDIN is a p53-responsive long non-coding RNA that is essential for genomic stability","volume":"20","author":"Hu","year":"2018","journal-title":"Nat Cell Biol"},{"key":"2026051916122336500_noag017-B32","doi-asserted-by":"publisher","first-page":"e104133","DOI":"10.15252\/embj.2019104133","article-title":"BGL3 lncRNA mediates retention of the BRCA1\/BARD1 complex at DNA damage sites","volume":"39","author":"Hu","year":"2020","journal-title":"Embo J"},{"key":"2026051916122336500_noag017-B33","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.15252\/embr.201540437","article-title":"A BRCA 1-interacting lnc RNA regulates homologous recombination","volume":"16","author":"Sharma","year":"2015","journal-title":"EMBO Rep"},{"key":"2026051916122336500_noag017-B34","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/nsmb.3211","article-title":"Long noncoding RNA LINP1 regulates repair of DNA double-strand breaks in triple-negative breast cancer","volume":"23","author":"Zhang","year":"2016","journal-title":"Nat Struct Mol Biol"},{"key":"2026051916122336500_noag017-B35","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1080\/15384101.2018.1442625","article-title":"LINP1 facilitates DNA damage repair through non-homologous end joining (NHEJ) pathway and subsequently decreases the sensitivity of cervical cancer cells to ionizing radiation","volume":"17","author":"Wang","year":"2018","journal-title":"Cell Cycle"},{"key":"2026051916122336500_noag017-B36","doi-asserted-by":"publisher","first-page":"eaaw1868","DOI":"10.1126\/scitranslmed.aaw1868","article-title":"Long noncoding RNA SNHG12 integrates a DNA-PK\u2013mediated DNA damage response and vascular senescence","volume":"12","author":"Haemmig","year":"2020","journal-title":"Sci Transl Med"},{"key":"2026051916122336500_noag017-B37","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1038\/s41467-022-28646-5","article-title":"Small cajal body-associated RNA 2 (scaRNA2) regulates DNA repair pathway choice by inhibiting DNA-PK","volume":"13","author":"Bergstrand","year":"2022","journal-title":"Nat Commun"},{"key":"2026051916122336500_noag017-B38","doi-asserted-by":"publisher","first-page":"3672","DOI":"10.1038\/s41596-021-00555-9","article-title":"iDRiP for the systematic discovery of proteins bound directly to noncoding RNA","volume":"16","author":"Chu","year":"2021","journal-title":"Nat Protoc"},{"key":"2026051916122336500_noag017-B39","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1038\/sj.onc.1210001","article-title":"Repression of RAD51 gene expression by E2F4\/p130 complexes in hypoxia","volume":"26","author":"Bindra","year":"2007","journal-title":"Oncogene"},{"key":"2026051916122336500_noag017-B40","doi-asserted-by":"publisher","first-page":"11597","DOI":"10.1158\/0008-5472.CAN-05-2119","article-title":"Hypoxia-Induced down-regulation of BRCA1 expression by E2Fs","volume":"65","author":"Bindra","year":"2005","journal-title":"Cancer Res"},{"key":"2026051916122336500_noag017-B41","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nrm.2017.48","article-title":"Non-homologous DNA end joining and alternative pathways to double-strand break repair","volume":"18","author":"Chang","year":"2017","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2026051916122336500_noag017-B42","doi-asserted-by":"publisher","first-page":"e2213715120","DOI":"10.1073\/pnas.2213715120","article-title":"The lncRNA LUCAT1 is elevated in inflammatory disease and restrains inflammation by regulating the splicing and stability of NR4A2","volume":"120","author":"Vierbuchen","year":"2023","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026051916122336500_noag017-B43","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s41586-020-2041-2","article-title":"DNA-PKcs has KU-dependent function in rRNA processing and haematopoiesis","volume":"579","author":"Shao","year":"2020","journal-title":"Nature"},{"key":"2026051916122336500_noag017-B44","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1093\/nar\/gki342","article-title":"Human Ku70\/80 interacts directly with hTR, the RNA component of human telomerase","volume":"33","author":"Ting","year":"2005","journal-title":"Nucleic Acids Res"},{"key":"2026051916122336500_noag017-B45","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1242\/jcs.078030","article-title":"A DNA-dependent stress response involving DNA-PK occurs in hypoxic cells and contributes to cellular adaptation to hypoxia","volume":"124","author":"Bouquet","year":"2011","journal-title":"J Cell Sci"},{"key":"2026051916122336500_noag017-B46","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/s41467-021-27944-8","article-title":"HIF-1 interacts with TRIM28 and DNA-PK to release paused RNA polymerase II and activate target gene transcription in response to hypoxia","volume":"13","author":"Yang","year":"2022","journal-title":"Nat Commun"},{"key":"2026051916122336500_noag017-B47","doi-asserted-by":"publisher","first-page":"3881","DOI":"10.1128\/MCB.02366-06","article-title":"Trans autophosphorylation at DNA-dependent protein kinase\u2019s two major autophosphorylation site clusters facilitates end processing but not end joining","volume":"27","author":"Meek","year":"2007","journal-title":"Mol Cell Biol"},{"key":"2026051916122336500_noag017-B48","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.molcel.2021.11.025","article-title":"Autophosphorylation transforms DNA-PK from protecting to processing DNA ends","volume":"82","author":"Liu","year":"2022","journal-title":"Mol Cell"},{"key":"2026051916122336500_noag017-B49","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1158\/1541-7786.MCR-12-0482-T","article-title":"Threonine 2609 phosphorylation of the DNA-dependent protein kinase is a critical prerequisite for epidermal growth factor receptor\u2013mediated radiation resistance","volume":"10","author":"Javvadi","year":"2012","journal-title":"Mol Cancer Res"},{"key":"2026051916122336500_noag017-B50","doi-asserted-by":"publisher","first-page":"22953","DOI":"10.1073\/pnas.2007455117","article-title":"DNA-PKcs phosphorylation at the T2609 cluster alters the repair pathway choice during immunoglobulin class switch recombination","volume":"117","author":"Crowe","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026051916122336500_noag017-B51","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abc7275","article-title":"Inhibiting DNA-PK induces glioma stem cell differentiation and sensitizes glioblastoma to radiation in mice","volume":"13","author":"Fang","year":"2021","journal-title":"Sci Transl Med"},{"key":"2026051916122336500_noag017-B52","doi-asserted-by":"publisher","first-page":"vdab015","DOI":"10.1093\/noajnl\/vdab015","article-title":"The promise of DNA damage response inhibitors for the treatment of glioblastoma","volume":"3","author":"Majd","year":"2021","journal-title":"Neurooncol Adv"},{"key":"2026051916122336500_noag017-B53","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1158\/0008-5472.CAN-09-1707","article-title":"Transcriptional profiles of CD133+ and CD133- glioblastoma-derived cancer stem cell lines suggest different cells of origin","volume":"70","author":"Lottaz","year":"2010","journal-title":"Cancer Res"},{"key":"2026051916122336500_noag017-B54","doi-asserted-by":"publisher","first-page":"eadd8280","DOI":"10.1126\/scitranslmed.add8280","article-title":"Antisense oligonucleotide therapy for H3.3K27M diffuse midline glioma","volume":"15","author":"Zhang","year":"2023","journal-title":"Sci Transl Med"},{"key":"2026051916122336500_noag017-B55","doi-asserted-by":"publisher","first-page":"e22187","DOI":"10.1002\/ddr.22187","article-title":"Unveiling the potential of antisense oligonucleotides: mechanisms, therapies, and safety insights","volume":"85","author":"Ers\u00f6z","year":"2024","journal-title":"Drug Dev Res"}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/advance-article-pdf\/doi\/10.1093\/neuonc\/noag017\/66678236\/noag017.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/28\/5\/1179\/66678236\/noag017.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/28\/5\/1179\/66678236\/noag017.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T20:12:30Z","timestamp":1779221550000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article\/28\/5\/1179\/8450323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,31]]},"references-count":55,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,1,31]]},"published-print":{"date-parts":[[2026,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/neuonc\/noag017","relation":{},"ISSN":["1522-8517","1523-5866"],"issn-type":[{"value":"1522-8517","type":"print"},{"value":"1523-5866","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5]]},"published":{"date-parts":[[2026,1,31]]}}}